SCOPIA CAPITAL MANAGEMENT LP - Q4 2016 holdings

$5.28 Billion is the total value of SCOPIA CAPITAL MANAGEMENT LP's 38 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 100.0% .

 Value Shares↓ Weighting
AMSC ExitAMERICAN SUPERCONDUCTOR CORP$0-19,610
-100.0%
-0.00%
MNKD ExitMANNKIND CORP$0-4,914,641
-100.0%
-0.05%
WAB ExitWABTEC CORP$0-120,648
-100.0%
-0.17%
GBX ExitGREENBRIER COS INC$0-285,846
-100.0%
-0.18%
FOSL ExitFOSSIL GROUP INC$0-395,925
-100.0%
-0.19%
AEGR ExitAEGERION PHARMACEUTICALS INC$0-5,703,587
-100.0%
-0.30%
BA ExitBOEING CO$0-304,927
-100.0%
-0.71%
NFLX ExitNETFLIX INCcall$0-500,000
-100.0%
-0.87%
MYGN ExitMYRIAD GENETICS INC$0-3,659,647
-100.0%
-1.33%
DST ExitDST SYS INC DEL$0-951,411
-100.0%
-1.98%
SERV ExitSERVICEMASTER GLOBAL HLDGS I$0-3,436,713
-100.0%
-2.04%
PRGO ExitPERRIGO CO PLC$0-3,022,503
-100.0%
-4.92%
SPY ExitSPDR S&P 500 ETF TRput$0-1,661,000
-100.0%
-6.34%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-02-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPIRIT AEROSYSTEMS HLDGS INC39Q4 202228.3%
SPDR S&P 500 ETF TR31Q3 202316.9%
ISHARES TR28Q3 202310.9%
MANNKIND CORP24Q3 20230.5%
BAIDU INC21Q2 20188.6%
ITRON INC21Q3 202012.1%
RETROPHIN INC20Q3 20204.5%
HARMONIC INC19Q3 202310.5%
JOHNSON CTLS INTL PLC17Q3 20209.6%
ACORDA THERAPEUTICS INC17Q3 20194.0%

View SCOPIA CAPITAL MANAGEMENT LP's complete holdings history.

Latest significant ownerships (13-D/G)
SCOPIA CAPITAL MANAGEMENT LP Q4 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
VERRA MOBILITY CorpOctober 28, 20226,710,0744.4%
Spirit AeroSystems Holdings, Inc.February 14, 20222,084,2122.0%
Retrophin, Inc.February 14, 20202,011,6974.7%
Horizon Therapeutics Public Ltd CoJanuary 10, 20202,527,4561.4%
ZOGENIX, INC.January 10, 2020919,4842.1%
ITRON, INC.January 07, 20201,808,0594.6%
ACORDA THERAPEUTICS INCSold outNovember 12, 201900.0%
LA JOLLA PHARMACEUTICAL COApril 10, 2019480,0001.8%
Prothena Corp plcMarch 11, 20191,883,8164.7%
GW PHARMACEUTICALS PLCFebruary 14, 20191,345,1984.6%

View SCOPIA CAPITAL MANAGEMENT LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D2024-04-26
13F-HR2024-02-14
SC 13G2024-02-14
SC 13D/A2024-01-22
13F-HR/A2023-11-14
13F-HR2023-11-14
SC 13D2023-09-21
13F-HR2023-08-14
13F-HR2023-05-15
SC 13D/A2023-04-12

View SCOPIA CAPITAL MANAGEMENT LP's complete filings history.

Compare quarters

Export SCOPIA CAPITAL MANAGEMENT LP's holdings